Parents and Caregivers

father holding son

Canvas Dx is a prescription-only product. Ask your doctor if Canvas Dx is right for your child.

Our team is here to help with:

  • Understanding insurance coverage and navigating the insurance authorization process.
  •  Using the Canvas Dx parent/caregiver app once it is prescribed for your child.
  •  Troubleshooting any technical problems that may arise in the use of Canvas Dx.
Caregiver User Guide

Healthcare Providers

Doctor Picture

Cognoa has contracted with Orsini Specialty Pharmacy to receive Canvas Dx prescriptions, adjudicate claims with insurance, and dispense patient-specific access codes to parents/caregivers. Cognoa Connect’s customer service team will be the single point of contact for product questions and technical support for both caregivers and prescribing physicians.

HCP User Guide

How can we support you today?

Cognoa Connect is Cognoa’s customer service team dedicated to supporting Canvas Dx. Whether you’re a concerned parent or caregiver or a healthcare provider, Cognoa Connect aims to get you the answers you need to successfully prescribe or use Canvas Dx. Our goal is to provide the best possible customer support for Canvas Dx.

Canvas Dx Logo
.

Canvas Dx is a prescription-based diagnosis aid for autism spectrum disorder (ASD), approved for use in children aged 18-72 months at risk for developmental delay. To learn more about Canvas Dx, click here

. CanvasDx.com
.

Cognoa is a pediatric behavioral health company developing diagnostic and therapeutic solutions with the goals of enabling equitable access to care and improving the lives and outcomes of children and families living with behavioral health conditions, starting with autism.

. Cognoa.com

© Cognoa 2023

Canvas Dx is intended for use by healthcare providers as an aid in the diagnosis of Autism Spectrum Disorder (ASD) for patients ages 18 months through 72 months who are at risk for developmental delay based on concerns of a parent, caregiver, or healthcare provider.

The device is not intended for use as a stand-alone diagnostic device but as an adjunct to the diagnostic process.

The device is for prescription use only (Rx only).

There are no contraindications to using Canvas Dx. 

The Device is intended for use by healthcare professionals trained and qualified to interpret the results of a behavioral assessment examination and to diagnose ASD.

The Device is intended for use in conjunction with patient history, clinical observations, and other clinical evidence the HCP determines are necessary before making clinical decisions. For instance, additional standardized testing may be sought to confirm the Device output, especially when the Device result is not Positive or Negative for ASD.

Canvas Dx is intended for patients with caregivers who have functional English capability (8th grade reading level or above) and have access to a compatible smartphone with an internet connection in the home environment.

The Device may give unreliable results if used in patients with other conditions that would have excluded them from the clinical study. Among those conditions are the following:

  • Suspected auditory or visual hallucinations or with prior diagnosis of childhood onset schizophrenia.
  • Known deafness or blindness.
  • Known physical impairment affecting their ability to use their hands.
  • Major dysmorphic features or prenatal exposure to teratogens such as fetal alcohol syndrome.
  • History or diagnosis of genetic conditions (such as Rett syndrome or Fragile X).
  • Microcephaly.
  • History or prior diagnosis of epilepsy or seizures.
  • History of or suspected neglect.
  • History of brain defect injury or insult requiring interventions such as surgery or chronic medication.

The Device evaluation should be completed within 60 days of the time it is prescribed because neurodevelopmental milestones change rapidly in the indicated age group.